Eton Pharmaceuticals (ETON) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $26.8 million.
- Eton Pharmaceuticals' Shares Outstanding rose 379.83% to $26.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year increase of 379.83%. This contributed to the annual value of $26.7 million for FY2024, which is 397.47% up from last year.
- Per Eton Pharmaceuticals' latest filing, its Shares Outstanding stood at $26.8 million for Q3 2025, which was up 379.83% from $26.8 million recorded in Q2 2025.
- Eton Pharmaceuticals' Shares Outstanding's 5-year high stood at $25.7 billion during Q1 2024, with a 5-year trough of $24.5 million in Q1 2021.
- Its 5-year average for Shares Outstanding is $1.4 billion, with a median of $25.6 million in 2023.
- In the last 5 years, Eton Pharmaceuticals' Shares Outstanding skyrocketed by 10063000.8% in 2024 and then crashed by 9989.56% in 2025.
- Over the past 5 years, Eton Pharmaceuticals' Shares Outstanding (Quarter) stood at $24.6 million in 2021, then grew by 2.95% to $25.4 million in 2022, then grew by 1.32% to $25.7 million in 2023, then grew by 3.97% to $26.7 million in 2024, then rose by 0.41% to $26.8 million in 2025.
- Its last three reported values are $26.8 million in Q3 2025, $26.8 million for Q2 2025, and $26.8 million during Q1 2025.